ZNF217 A NEW PROGNOSTIC AND PREDICTIVE BIOMARKER OF RECURRENT, INVASIVE AND METASTATIC PHENOTYPES IN BREAST CANCER

摘要

The present invention relates to methods for determining the prognosis of a cancer. The methods involve determining the level of expression of the ZNF217 gene in a cancer cell sample or in a tumor sample wherein over-expression of ZNF217 is correlated with likelihood of metastasis and with likelihood of relapse/recurrence of the cancer.